Gilead Sciences, Inc. (GILD)
168.06
+0.11
(+0.07%)
USD |
NASDAQ |
Nov 13, 16:00
167.94
-0.12
(-0.07%)
After-Hours: 19:59
Gilead Sciences Price : 168.06 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 171.15 | 171.70 | 167.93 | 167.95 | 4.234M |
| Nov 11, 2026 | 169.45 | 170.48 | 168.37 | 169.73 | 4.884M |
| Nov 10, 2026 | 170.15 | 171.15 | 167.60 | 170.87 | 4.831M |
| Nov 09, 2026 | 169.21 | 170.11 | 165.98 | 169.32 | 4.472M |
| Nov 06, 2026 | 164.11 | 169.06 | 164.00 | 166.89 | 5.818M |
| Nov 05, 2026 | 174.54 | 176.58 | 167.09 | 167.57 | 11.36M |
| Nov 04, 2026 | 171.89 | 175.41 | 168.84 | 174.48 | 9.637M |
| Nov 03, 2026 | 170.54 | 172.00 | 167.43 | 167.47 | 6.607M |
| Nov 02, 2026 | 169.85 | 172.61 | 166.38 | 170.33 | 8.876M |
| Oct 30, 2026 | 170.25 | 175.65 | 169.00 | 170.68 | 11.43M |
| Oct 29, 2026 | 162.89 | 165.70 | 160.86 | 165.61 | 8.432M |
| Oct 28, 2026 | 157.28 | 160.83 | 156.04 | 159.20 | 5.002M |
| Oct 27, 2026 | 156.05 | 159.28 | 155.76 | 159.08 | 4.935M |
| Oct 26, 2026 | 157.62 | 159.69 | 157.52 | 158.69 | 6.048M |
| Oct 23, 2026 | 156.47 | 157.65 | 155.76 | 156.04 | 6.071M |
| Oct 22, 2026 | 154.24 | 157.42 | 153.00 | 157.19 | 6.211M |
| Oct 21, 2026 | 154.73 | 155.42 | 151.71 | 153.57 | 6.221M |
| Oct 20, 2026 | 155.37 | 157.48 | 154.02 | 156.51 | 5.793M |
| Oct 19, 2026 | 155.38 | 157.24 | 152.92 | 153.07 | 6.835M |
| Oct 16, 2026 | 157.32 | 157.58 | 155.62 | 156.19 | 7.772M |
| Oct 15, 2026 | 156.39 | 160.51 | 156.02 | 157.37 | 8.288M |
| Oct 14, 2026 | 148.19 | 153.76 | 147.48 | 153.54 | 5.761M |
| Oct 13, 2026 | 151.16 | 151.16 | 147.26 | 147.92 | 5.558M |
| Oct 12, 2026 | 151.84 | 152.26 | 149.80 | 150.43 | 5.792M |
| Oct 09, 2026 | 147.23 | 151.44 | 146.10 | 151.17 | 5.802M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Regeneron Pharmaceuticals, Inc. | 955.36 |
| AbbVie, Inc. | 295.01 |
| Biogen, Inc. | 253.41 |
| Vertex Pharmaceuticals, Inc. | 538.63 |
| Amgen, Inc. | 465.57 |
Price Related Metrics
| PS Ratio | 6.764 |
| Price to Book Value | 16.00 |
| Price to Free Cash Flow | 15.25 |
| Earnings Yield | -1.87% |
| Market Cap | 208.56B |
| Operating PE Ratio | 17.62 |
| Normalized PE Ratio | 36.77 |